Longitudinal cohort study reports cancer rates and evaluates IGF-1 levels in 598 patients with acromegaly, highlighting hormone monitoring for oncologic risk.
Long-term GH/IGF-1 excess could increase risk of cancer in acromegaly, but individual levels of these hormones do not relate to this risk. Therefore, we newly investigated longitudinally-measured IGF-1 levels as a potential predictor of cancer in a large NYC acromegaly cohort.
No takes yet. Share an insight, caveat, or question.
Freda et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: